# Comparing Rezum and Urolift

> **NCT06820606** · NA · RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 120 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** Rezum
- **DEVICE:** UroLift

## Key facts

- **NCT ID:** NCT06820606
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2027-09-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06820606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06820606, "Comparing Rezum and Urolift". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06820606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*